Get the Stockscreener App
8.18
2.04%
-0.17
Pre-market:
8.00
-0.18
-2.20%
89 Bio Inc Stock (ETNB) Forecast
The 89 Bio Inc (ETNB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $16.70, representing a +104.17% increase from the current price of $8.18. The highest analyst price target is $26.31, and the lowest is $7.0963.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ETNB Price Target
Average 13.67
(+67.09% Upside)
Is 89 Bio Inc (ETNB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 42.49 | Neutral |
| STOCH(9,6) | 22.39 | Neutral |
| STOCHRSI(14) | 57.08 | Neutral |
| MACD(12,26) | -0.4428 | Sell |
| ADX(14) | 26.10 | Sell |
| William %R | -69.73 | Neutral |
| CCI(14) | -18.50 | Neutral |
Buy: 0
Sell: 2
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
8.261
Sell
|
8.3537
Sell
|
| MA20 |
9.301
Sell
|
8.8238
Sell
|
| MA50 |
8.7797
Sell
|
8.9032
Sell
|
| MA100 |
8.5954
Sell
|
8.721
Sell
|
| MA200 |
8.4332
Sell
|
8.8136
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ETNB could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 12 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on ETNB, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 42.49 indicates that ETNB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 22.39 indicates that ETNB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 57.08 indicates that ETNB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 26.1 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -18.5 indicates that ETNB is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ETNB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about 89 Bio Inc financial reports and earnings history, 89 Bio Inc (ETNB) stock could reach $8.5642 by 2030, $43.67 by 2040 and $79.68 by 2050. See the projected annual prices until 2050 of the 89 Bio Inc stock below:
- 89 Bio Inc (ETNB) is expected to reach an average price of $27.43 in 2035, with a high prediction of $24.03 and a low estimate of $24.87. This indicates an $235.38% rise from the last recorded price of $8.18.
- 89 Bio Inc (ETNB) stock is projected to chart a bullish course in 2040, with an average price target of $36.57, representing an $347.03% surge from its current level. The forecast ranges from a conservative $45.09 to a sky-high $43.67.
- Our analysts predict 89 Bio Inc (ETNB) to jump 625.66% by 2045, soaring from $63.59 to an average price of $59.36, potentially reaching $62.25. While $63.59 is the low estimate, the potential upside is significant.
- 89 Bio Inc (ETNB) stock is expected to climb by 2050, reaching an average of $81.93, a $901.62% jump from its current level. However, a wide range of estimates exists, with high and low targets of $79.68 and $79.11, respectively, highlighting the market's uncertainty.
89 Bio Inc Stock (ETNB) Year by Year Forecast
89 Bio Inc Stock (ETNB) Price Forecast for 2025
89 Bio Inc Stock (ETNB) is expected to reach an average price of $13.88 in 2025, with a high prediction of $26.31 and a low estimate of $1.4461. This indicates an +69.63% rise from the last recorded price of $8.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2025 | $9.793 | $7.0963 | $26.31 | +19.72% |
| May, 2025 | $8.8399 | $6.5332 | $11.32 | +8.07% |
| June, 2025 | $12.11 | $7.1834 | $12.76 | +48.01% |
| July, 2025 | $10.75 | $9.8137 | $12.98 | +31.42% |
| August, 2025 | $6.3474 | $5.8906 | $12.78 | -22.40% |
| September, 2025 | $8.8043 | $4.3208 | $9.9743 | +7.63% |
| October, 2025 | $10.44 | $5.0144 | $10.84 | +27.60% |
| November, 2025 | $11.81 | $7.1446 | $12.69 | +44.44% |
| December, 2025 | $7.3984 | $5.7885 | $13.91 | -9.55% |
89 Bio Inc Stock (ETNB) Price Forecast for 2026
The predicted value for 89 Bio Inc (ETNB) in 2026 is set at an average of $4.4486. Estimates vary from a peak of $8.8852 to a trough of $0.0121, indicating an -45.62% surge from the present price of $8.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $5.3353 | $2.7119 | $8.8852 | -34.78% |
| February, 2026 | $3.5822 | $3.4722 | $8.3588 | -56.21% |
| March, 2026 | $1.9891 | $1.0291 | $4.839 | -75.68% |
| April, 2026 | $5.0728 | $1.5859 | $7.006 | -37.99% |
| May, 2026 | $6.4697 | $4.7695 | $8.1729 | -20.91% |
| June, 2026 | $5.1066 | $4.4399 | $7.9564 | -37.57% |
| July, 2026 | $3.0602 | $2.9602 | $6.9668 | -62.59% |
| August, 2026 | $0.9671 | $0.0121 | $3.2469 | -88.18% |
| September, 2026 | $0.2893 | $0.0751 | $2.614 | -96.46% |
| October, 2026 | $6.9924 | $2.6225 | $6.1724 | -14.52% |
| November, 2026 | $7.4054 | $7.3556 | $7.1354 | -9.47% |
| December, 2026 | $8.0318 | $8.0585 | $8.042 | -1.81% |
89 Bio Inc Stock (ETNB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for 89 Bio Inc (ETNB) is $4.8679, with a high forecast of $9.0615 and a low forecast of $0.6743. This indicates an -40.49% decrease from the last price of $8.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $8.9449 | $8.0051 | $8.5349 | +9.35% |
| February, 2027 | $8.308 | $8.898 | $9.0615 | +1.56% |
| March, 2027 | $8.0044 | $7.8611 | $8.2146 | -2.15% |
| April, 2027 | $7.4375 | $7.9142 | $7.7442 | -9.08% |
| May, 2027 | $7.2206 | $7.4153 | $7.334 | -11.73% |
| June, 2027 | $5.9069 | $6.0204 | $5.9069 | -27.79% |
| July, 2027 | $4.61 | $5.4387 | $5.4402 | -43.64% |
| August, 2027 | $0.9231 | $1.9731 | $1.8233 | -88.71% |
| September, 2027 | $1.6295 | $0.8764 | $1.2795 | -80.08% |
| October, 2027 | $0.7574 | $1.6526 | $1.4361 | -90.74% |
| November, 2027 | $0.8943 | $0.6743 | $3.2976 | -89.07% |
| December, 2027 | $4.5979 | $0.801 | $6.1279 | -43.79% |
89 Bio Inc Stock (ETNB) Price Forecast for 2028
In 2028, 89 Bio Inc (ETNB) is projected to reach an average price of $7.2511, with a high projection of $14.49 and a low estimate of $0.00976. This indicates an -11.36% fall from the last price of $8.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.9848 | $3.2847 | $5.2648 | -39.06% |
| February, 2028 | $6.2317 | $1.735 | $8.985 | -23.82% |
| March, 2028 | $7.9054 | $5.1252 | $8.9719 | -3.36% |
| April, 2028 | $9.6523 | $7.3755 | $10.29 | +18.00% |
| May, 2028 | $10.61 | $8.6059 | $14.49 | +29.66% |
| June, 2028 | $7.7828 | $6.7701 | $11.59 | -4.86% |
| July, 2028 | $8.2797 | $6.423 | $8.8497 | +1.22% |
| August, 2028 | $9.6233 | $7.9464 | $10.47 | +17.64% |
| September, 2028 | $0.0702 | $0.00976 | $9.8401 | -99.14% |
| October, 2028 | $1.0471 | $0.0371 | $1.2171 | -87.20% |
| November, 2028 | $1.2708 | $0.104 | $1.3939 | -84.46% |
| December, 2028 | $4.2277 | $1.6275 | $4.5227 | -48.32% |
89 Bio Inc Stock (ETNB) Price Forecast for 2029
The 2029 price forecast for 89 Bio Inc Stock (ETNB) is $6.3515 on average, with a high prediction of $12.34 and a low estimate of $0.3613. This represents an -22.35% decrease from the previous price of $8.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.1913 | $3.1413 | $5.2511 | -60.99% |
| February, 2029 | $4.6582 | $0.8548 | $4.8982 | -43.05% |
| March, 2029 | $7.1851 | $4.2849 | $10.25 | -12.16% |
| April, 2029 | $3.672 | $3.502 | $7.4218 | -55.11% |
| May, 2029 | $9.50 | $1.9855 | $9.085 | +16.14% |
| June, 2029 | $4.4362 | $8.3131 | $9.7835 | -45.77% |
| July, 2029 | $8.9224 | $11.26 | $8.0958 | +9.08% |
| August, 2029 | $9.2951 | $10.02 | $7.7689 | +13.63% |
| September, 2029 | $3.2887 | $0.3613 | $12.34 | -59.80% |
| October, 2029 | $13.04 | $10.04 | $10.23 | +59.46% |
| November, 2029 | $10.56 | $11.02 | $10.87 | +29.10% |
| December, 2029 | $7.6964 | $8.0264 | $9.6968 | -5.91% |
89 Bio Inc Stock (ETNB) Price Forecast for 2030
89 Bio Inc Stock (ETNB) is expected to reach an average price of $5.95 in 2030, with a high forecast of $11.64 and a low forecast of $0.2643. This signifies an -27.26% decrease from the last price of $8.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $11.98 | $8.883 | $8.5642 | +46.44% |
| February, 2030 | $0.3554 | $2.9854 | $11.64 | -95.66% |
| March, 2030 | $2.4716 | $1.9519 | $3.4181 | -69.79% |
| April, 2030 | $4.7122 | $0.7803 | $10.25 | -42.39% |
| May, 2030 | $5.9405 | $0.2643 | $9.0191 | -27.38% |
| June, 2030 | $8.1067 | $7.8501 | $6.9636 | -0.90% |
| July, 2030 | $3.7494 | $4.1329 | $5.7232 | -54.16% |
| August, 2030 | $3.2356 | $4.556 | $3.2325 | -60.44% |
| September, 2030 | $9.3218 | $6.0922 | $8.2818 | +13.96% |
| October, 2030 | $5.0246 | $6.7415 | $7.6184 | -38.58% |
| November, 2030 | $4.0908 | $5.7542 | $4.2077 | -49.99% |
| December, 2030 | $3.9769 | $5.4804 | $4.9738 | -51.38% |
1.39%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):